INFORMED.
LIVE

Aarti Drugs Limited

BSE: AARTIDRUGS524348ISIN INE767A01016
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹431.75+4.55 (+1.07%)
as of 18 Sep 2026
Aarti Drugs Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹516.20 to ₹431.75 (-16.4%). Low ₹330.60, high ₹520.35. Volume shown below the price.
52W high
₹534.15
52W low
₹318.60
Off 52W high
-19.17%
1M return
+5.69%
3M return
+16.45%
6M return
+25.73%
1Y return
-16.36%
20D avg volume
9,952
50 DMA
₹418.33
200 DMA
₹387.46

Key ratios Consolidated

Market cap
₹3,941 Cr
Current price
₹431.75
52W high / low
₹534.15 / ₹318.60
Face value
₹10.00
P/E
20.62
P/B
EPS (TTM)
₹20.94
Book value / share
ROE
ROCE
12.90%
Operating margin
Net margin
Debt / equity
0.37
Net debt
₹567.56 Cr
Interest cover
7.26
Dividend yield
0.46%
Dividend / share (TTM)
₹2.00
Payout
9.55%
Cash conversion cycle
119.9 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q1 FY25Q4 FY24
Income statement
702.78720.30601.71652.79590.51676.76590.51
0.810.761.230.090.311.870.31
632.26650.70573.92592.47539.71607.48539.71
469.35427.19334.52385.06357.25375.14357.25
21.3833.3222.5130.6428.6123.1328.61
36.5132.2833.1633.0730.8031.3530.80
9.228.169.297.708.569.168.56
18.4618.0417.9516.2614.7214.8814.72
140.47141.80126.88127.15112.24115.18112.24
71.3370.3629.0260.4151.1171.1551.11
-2.090.000.000.000.000.000.00
69.2470.3629.0260.4151.1171.1551.11
19.1115.10-11.5315.25-2.868.38-2.86
50.1355.2640.5545.1653.9762.7753.97
5.496.054.444.955.916.885.91
Key metrics
96.9296.5656.2684.3774.3995.1974.39
13.80%13.40%9.40%12.90%12.60%14.10%12.60%
7.10%7.70%6.70%6.90%9.10%9.30%9.10%
4.10%3.70%4.60%
19.00%6.40%0.00%
-7.10%-12.00%0.00%
MetricTTMFY26FY25FY24
Income statement
2,6782,5652,387
2.892.3916.36
2,4492,3572,192
1,6161,5041,438
107.85115.0884.34
135.02129.32112.10
34.3733.7135.87
70.7166.9755.78
536.30508.08445.77
231.12210.90211.77
-2.090.000.00
229.03210.90211.77
37.9315.9643.67
191.10194.94168.10
20.9321.3618.35
Key metrics
334.11311.58303.42
12.48%12.10%12.70%
7.14%7.60%7.00%
12.90%14.30%
7.50%
16.00%
80.2267.42
1.301.45
0.370.45
567.56607.66
119.9123.6
Balance sheet
2,8152,575
1,4681,338
7.274.58
829.87751.18
490.78472.93
122.1480.88
1,068856.25
477.88416.14
922.25836.97
574.83612.24
317.96328.24
256.87284.00
1,5491,369
Cash flow
253.54244.58
-173.41-164.63
-77.44-82.12
173.32177.16
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
627.45631.68528.80578.95520.96622.96
0.200.831.220.150.381.71
557.71573.95508.31523.32476.09554.00
434.56399.29307.25361.49333.81351.48
12.4512.1212.349.8411.2113.49
26.3423.2125.0324.7423.2923.40
6.956.596.956.016.827.48
15.2114.9514.8713.5512.2712.21
119.86123.72111.69112.67101.34104.85
69.9458.5621.7155.7845.2570.67
-2.090.000.000.000.000.00
67.8558.5621.7155.7845.2570.67
17.0013.60-12.1314.00-3.399.19
50.8544.9633.8441.7848.6461.48
5.574.933.714.585.336.74
Key metrics
90.0180.1043.5375.3464.3490.36
14.30%12.70%8.20%13.00%12.40%14.50%
8.10%7.10%6.40%7.20%9.30%9.90%
3.90%3.80%5.00%
20.40%1.40%
4.50%-26.90%
MetricTTMFY26FY25FY24
Income statement
2,3672,2602,174
2.402.5913.58
2,1632,0821,988
1,5031,4021,358
46.7545.5144.34
99.3296.2785.25
26.5026.3829.68
58.5855.6447.79
467.94449.40401.08
205.99181.31198.75
-2.090.000.00
203.90181.31198.75
32.4712.0941.44
171.43169.22157.31
18.7918.5417.18
Key metrics
288.98263.33276.22
12.21%11.60%12.70%
7.24%7.50%7.20%
12.40%14.60%
4.00%
7.60%
151.7582.79
1.501.40
0.300.41
416.40510.64
117.1123.5
Balance sheet
2,3822,273
1,2131,181
3.573.28
732.41701.72
405.35407.23
54.6840.37
970.31759.57
413.31373.11
712.63705.78
419.97513.92
238.27275.97
181.70237.95
1,4051,251
Cash flow
254.14220.08
-127.58-134.92
-126.27-84.60
102.39137.29

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
54.42%
HolderTypeHoldingPreviousChange
Prakash Moreshwar PatilPromoter9.62%
DSP Small Cap FundPublic7.93%
Harshit Manilal SavlaPromoter4.73%
Rashesh Chandrakant GogriPromoter Group4.64%
Priti Prakash PatilPromoter Group4.40%
Seema Harshit SavlaPromoter Group3.83%
Gogri Finserv Pvt. Ltd.Promoter Group3.80%
Hetal Gogri GalaPromoter Group3.05%
Harit Pragji ShahPublic2.67%
Anushakti Enterprise Private LimitedPromoter Group2.62%
Alchemie Finserv Pvt. Ltd.Promoter Group2.21%
ICICI Prudential Pharma Healthcare And Diaganostics (P.H.D) FundPublic2.04%
Chandrakant Vallabhaji GogriPromoter1.87%
Jayshree Harit ShahPublic1.78%
Jaya Chandrakant GogriPromoter Group1.71%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Interim Dividend - Rs. - 2.00009 Feb 20269 Feb 2026
Interim Dividend - Rs. - 1.00004 Feb 20254 Feb 2025
Buy Back of Shares5 Sep 20245 Sep 2024

Board meetings

  • Board Meeting - Financial Results